MOG and acute disseminated encephalomyelitis: The MOG antibody has been identified in inflammatory demyelinating diseases (IDDs), including acute disseminated encephalomyelitis (ADEM), neuromyelitis optica spectrum disorders (NMOSDs), optic neuritis (ON), transverse myelitis (TM), clinically isolated syndrome, and multiple sclerosis (MS).